Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of ACYW135 Meningococcal Conjugate Vaccine in Infants
NCT05935176Phase 4Active, not recruiting
- Sponsor
- CanSino Biologics Inc.
- Start
- Sep 2023
- Primary completion
- May 2026
- Countries
- 1
01
Overview
A Phase 4 trial of acyw135 meningococcal conjugate vaccine crm197 in meningococcal meningitis, sponsored by CanSino Biologics Inc.. Started Sep 2023; status: active, not recruiting.
02
Drugs
acyw135 meningococcal conjugate vaccine crm197
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT05935176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935176.